Ask any early-stage medtech or digital health entrepreneur, and they’ll tell you how tough it is. There’s tremendous competition for venture investing, coupled with a pullback by previously traditional investors in this space. Bill Evans While venture investment in medtech and digital health has recovered since the financial crisis of a decade ago — setting […]
Silicon Valley Bank
Report: Big data, AI hold “greatest promise” for healthcare tech
Big data and artificial intelligence will have the greatest impact in the health-tech industry in the year ahead, according to a survey released yesterday. The survey, performed by Silicon Valley Bank, polled 122 founders, execs and investors in health care technology companies about the biggest challenges, most promising technology and biggest growth sectors in the […]
Silicon Valley Bank’s Ben Johnson talks early-stage medtech investment slump | Medtech funding for the week of September 22, 2014
What’s behind the slump in early-stage medtech investment?
It’s a hard world out there for those looking to turn their cutting edge medical device ideas into commercial products, with investors shying away from early-stage companies in favor of more established medtech enterprises.
Lack of FDA approval is no longer a deal-breaker for a big exit | The week in medtech M&A
Report: Medtech M&A exits don’t hinge on FDA approval
The funding environment for medical device startups isn’t a pretty scene, but there is a ray of sunshine through the gloom: lack of FDA approval is no longer a deal-breaker for a big exit.
In 2013 a few medtech companies managed "big exit M&A" deals (those worth $50 million or more) without having reached the FDA’s brass ring, according to a new report from Silicon Valley Bank.
Survey: Medtech startups respond to the medical device tax
There are few surprises in the medtech industry’s outlook on the impact of the medical device tax, but the burden weighs heavier on the industry’s startups.
Funding: Who are the most active angel investors in healthcare?
If you’re a startup medical device company looking for an angel, it pays to go west, according to a new report.
The most active angel investors for medical device, diagnostics, biotechnology and other life science companies appear to be clustering, according to a new report by Silicon Valley Bank and the Angel Resource Institute.
VCs press Senate on “IPO On Ramp” bill | Wall Street Beat
The National Venture Capital Assn. is spearheading a drive to get a bill through the U.S. Senate that would make it easier for small companies to raise money by going public.
The "IPO On Ramp" measure would ease the regulatory requirements for IPOs and temporarily reduce the reporting burdens imposed by the Sarbanes-Oxley Act.
Implantable Provider Group Secures a Three-Fold Increase in Their Line of Credit from Silicon Valley Bank
Implantable Provider Group Secures a Three-Fold Increase in Their Line of Credit from Silicon Valley Bank
ATLANTA–(BUSINESS WIRE)–Implantable Provider Group (IPG), a leader in providing market based medical implant solutions that deliver tangible value to payors, manufacturers, providers and patients, has secured a three-fold increase in their line of credit arrangement with Silicon Valley Bank. Profitable since inception in 2004, IPG has grown at a 76% compounded annual rate for the past seven years, with a primary focus on large, fast-growth device intensive markets, such as cardiology, neurology, orthopedic and spine implants.
